In this episode of <i>Ageless Future</i>, Cade Archibald dives deep into the growing world of GLP-1 peptides—like Semaglutide (Ozempic), Tirzepatide, and the newest, Retatrutide. He breaks down the science, benefits, and potential risks of these game-changing therapies for weight loss, blood sugar control, and metabolic health. Cade exposes common mistakes that lead to side effects such as muscle loss and GI issues, emphasizing the critical role of proper dosing, receptor resets, and stacking with supportive peptides. Most importantly, he outlines how combining these peptides with smart nutrition, strength training, and personalized care can create lasting, transformative results—avoiding the pitfalls of mainstream misuse and fad weight-loss hype. <br /><br />LIKE/FOLLOW/SUBSCRIBE AGELESS FUTURE:<br /><ul><li>YouTube -<a href="https://www.youtube.com/@ReganArchibald" target="_blank" rel="noreferrer noopener">https://www.youtube.com/@ReganArchibald / https://www.youtube.com/@Ageless.Future</a></li><li>LinkedIn: <a href="https://www.linkedin.com/in/regan-archibald-ab70b813" target="_blank" rel="noreferrer noopener">https://www.linkedin.com/in/regan-archibald-ab70b813</a></li><li>Instagram: <a href="https://www.instagram.com/ageless.future/" target="_blank" rel="noreferrer noopener">https://www.instagram.com/ageless.future/</a></li><li>Facebook: <a href="https://www.facebook.com/AgelessFutureHealth/" target="_blank" rel="noreferrer noopener">https://www.facebook.com/AgelessFutureHealth/</a></li></ul><br /><br />